# Suga.Health presentation refinement — 22 September 2026

Baseline: `642b67de7e11103ca35b0c6cab2409a85335ce97`.

## Design decisions

- Preserve public copy, content arrays, clinical information, routes, and workflows.
- Keep the existing monochrome identity and font families. Use Source Sans for editorial headings, Open Sans for clinical text, and existing brand typography.
- Alternate pathway chapters, connected milestones, open statistics, clinician profiles, and a structured formulary instead of repeating card grids.
- Use shared clinical typography and surfaces for Patient and Doctor pages. Retain every medical field; distinguish internal notes, patient explanations, medication directions, and estimated cost.
- Keep the six-step intake data and validation intact. Add an accessible progress rail, explicit selected states, and associated measurement labels.
- Preserve the prescription catalog and option architecture. Improve option grouping, medicine search feedback, and input hierarchy.
- Use native dialogs for public details and navigation, with focus containment and Escape dismissal.
- Reuse existing images with responsive CDN sizes; provide a neutral error fallback without replacing a clinician's portrait with an invented one.
- Limit motion to pathway image reveals, directional hover feedback, and existing progress transitions. Disable motion for reduced-motion preferences.
- Adapt public compositions at 640/900/1150px and the portal dock at 760px. Keep desktop sidebar behavior explicit across the former 960px breakpoint.

References: TypeUI marketing/application layout categories and Impeccable's shape, typeset, layout, clarify, animate, adapt, optimize, polish, and audit guidance.

## Verification performed

- TypeScript: passed.
- Production Next.js build: passed, including all public and protected routes.
- ESLint: passed with zero errors and zero warnings after removing three unused imports from the existing treatment pages.
- Automated comparison: all homepage data declarations unchanged.
- Automated comparison: consultation intake, clinical prescription builder, and treatment-selection state/validation/persistence code unchanged before rendering.
- Git diff review: no changes to Supabase schema, RLS, RPCs, server actions, auth implementation, or protected route data queries.
- Messaging frontend prop reconciliation moved from an effect to a guarded render update to satisfy lint. Realtime subscription, optimistic send, rollback, and server action unchanged.
- Live public checks: homepage and weight-loss page rendered; no desktop document overflow; formulary filter returned two hair treatments and six total treatments; selected-filter semantics updated; doctor and medicine dialogs opened; Escape and close button dismissed dialogs; FAQ expanded.
- Email/password authentication and role-aware redirects were verified on the live deployment with the isolated Patient and Doctor test accounts.
- Live Patient checks: home, consultation list and details, completed treatment options, messages, notifications, and profile rendered correctly. The six-step intake was traversed in full; unit selection, required-field and consent errors, save state, and draft persistence after reload were verified. The synthetic draft was deliberately not submitted for clinical review.
- Live Doctor checks: queue and empty state, active/completed case list, consultation review, patient-provided information, clinical notes, prescription options, medication-search empty state, local add/remove-option behavior, secure messages, notifications, and profile rendered correctly. No clinical record, profile, message, or notification state was saved during the review.
- Published refinement commits received successful Vercel deployment statuses through GitHub. Follow-up corrections address ticker minimum width, legacy section-blur specificity, and unavailable remote images.

## Remaining verification

This refinement is not a new clinical release sign-off. Creating a fake submitted consultation, completing treatment, sending a message, and repeating authorization-isolation tests were intentionally excluded from this presentation-only pass because those actions would change clinical workflow data. Existing workflow architecture and server code were left unchanged.

The available browser exposes no viewport-emulation or reduced-motion control. Mobile/tablet and reduced-motion rules were reviewed in code, including the five-item bottom dock, safe-area padding, single-column treatment and prescription layouts, 44px controls, intake rail compaction, dialog behavior, and motion overrides. Device-level visual and keyboard checks remain the only manual verification item. No test credentials, authorization bypasses, or backend changes were added for previewing screens.
